- Papers in database
- 7
- Primary author
- 1 paper
- Years active
- 1993 – 2019
Papers (7)
- 2019Primary authorSaccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers10.3389/fmicb.2019.00336
- 2016Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers10.1080/19490976.2016.1267890
- 2009Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.10.1053/j.gastro.2009.05.050
- 2008Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.10.1152/AJPGI.00391.2007
- 2006Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.10.1016/J.BBRC.2006.02.080
- 2001Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice10.1128/IAI.69.4.2762-2765.2001
- 1993Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.10.1016/0016-5085(93)90280-P